Yann Mazabraud serves as the Executive Vice President and Head of International at Rhythm Pharmaceuticals Inc., a biopharmaceutical company focused on developing and commercializing therapies for rare genetic disorders of obesity. In his role, Mazabraud is responsible for overseeing the company's international operations and expansion efforts, ensuring that Rhythm Pharmaceuticals can effectively reach and serve patients globally with their innovative treatments. Mazabraud brings a wealth of experience to his position, with a strong background in the biopharmaceutical industry. Prior to joining Rhythm Pharmaceuticals, he held various leadership roles at other prominent companies in the sector. His career has been marked by a dedication to advancing healthcare solutions and improving patient outcomes, particularly in the area of rare diseases. Mazabraud's strategic vision and deep understanding of the global market have been instrumental in driving Rhythm Pharmaceuticals' international growth and success. Under Mazabraud's leadership, Rhythm Pharmaceuticals has made significant strides in expanding its presence and impact on a global scale. His expertise in navigating complex international regulatory environments and building strong partnerships has been crucial in bringing the company's therapies to patients in need around the world. Mazabraud's commitment to innovation and patient-centric care continues to shape the company's mission and drive its efforts to transform the lives of those affected by rare genetic disorders.